Butler, Javed 
; Anker, Stefan D ; Lund, Lars H. ; Coats, Andrew J. S.; Filippatos, Gerasimos ; Siddiqi, Tariq Jamal; FRIEDE, Tim ; Fabien, Vincent ; Kosiborod, Mikhail; Metra, Marco
Fonte: European heart journal. Unidade: FM
Assuntos: PLACEBOS, POTÁSSIO, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUTLER, Javed et al. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial. European heart journal, v. 43, n. 41, p. 4362-4373, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50465. Acesso em: 06 jun. 2024.APA
Butler, J., Anker, S. D., Lund, L. H., Coats, A. J. S., Filippatos, G., Siddiqi, T. J., et al. (2022). Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial. European heart journal, 43( 41), 4362-4373. doi:10.1093/eurheartj/ehac401NLM
Butler J, Anker SD, Lund LH, Coats AJS, Filippatos G, Siddiqi TJ, FRIEDE T, Fabien V, Kosiborod M, Metra M. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial [Internet]. European heart journal. 2022 ; 43( 41): 4362-4373.[citado 2024 jun. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50465Vancouver
Butler J, Anker SD, Lund LH, Coats AJS, Filippatos G, Siddiqi TJ, FRIEDE T, Fabien V, Kosiborod M, Metra M. Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial [Internet]. European heart journal. 2022 ; 43( 41): 4362-4373.[citado 2024 jun. 06 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50465
